Skip to main content

Advertisement

Log in

Potentially inappropriate medications and cognitive performance: cross-sectional results from the ELSA–Brasil study

  • Research
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

A Correction to this article was published on 24 May 2023

This article has been updated

Abstract

Objectives

Potentially inappropriate medications (PIM), especially those with potential effects on the central nervous system, can increase the risk of cognitive impairment. We investigated the association of the use of PIM and PIM that may impair cognition (PIM-Cog) with cognitive performance among older adults.

Methods

In this cross-sectional study with 2,626 participants, PIM and PIM-Cog were defined by the 2019 American Geriatrics Society Beers criteria. We calculated global cognition and memory, verbal fluency, and Trail Making Test B version (TMT-B) z-scores. Linear regression models adjusted for sociodemographic and clinical variables were used to investigate the association between PIM and cognition.

Results

27% and 7% of the sample (mean age = 65.1 ± 4.1 years old, 54% women, and 61% White) used at least one PIM and PIM-cog, respectively. PIM was associated with poor performance in the TMT-B (β = -0.17, 95% Cl = -0.29; -0.05, p = 0.007). PIM-Cog was also associated with poor TMT-B performance (β = -0.08, 95% Cl = -0.15; -0.01, p = 0.025).

Conclusion

The use of PIM and PIM-Cog was associated with poor executive function among older adults. The review of PIM use and the deprescription of these drugs may be an effective way to improve cognitive function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and materials

Not applicable.

Change history

References

  1. Fick DM et al (2019) American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 67(4):674–694. https://doi.org/10.1111/jgs.15767

    Article  Google Scholar 

  2. Oliveira MG, Amorim WW, Oliveira CRB, Coqueiro HL, Gusmão LC, Passos LC (2017) Consenso brasileiro de medicamentos potencialmente inapropriados para idosos. Geriatr Gerontol Aging 10(4):168–181. https://doi.org/10.5327/z2447-211520161600054

    Article  Google Scholar 

  3. Borja-Oliveira CR, Assato CP (2015) Psicofármacos Potencialmente Inapropriados Para Idosos. Estud Interdiscip sobre o Envelhec 20(3). https://doi.org/10.22456/2316-2171.38548

  4. dos Santos ANM, Nogueira DRC, de Borja-Oliveira CR (2018) Self-medication among participants of an Open University of the Third Age and associated factors. Rev Bras Geriatr e Gerontol 21(4):419–427. https://doi.org/10.1590/1981-22562018021.170204

    Article  Google Scholar 

  5. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents. Arch Intern Med 151(9):1825–1832. https://doi.org/10.1001/archinte.1991.00400090107019

    Article  CAS  PubMed  Google Scholar 

  6. Samuel MJ (2015) American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227–2246. https://doi.org/10.1111/jgs.13702

    Article  Google Scholar 

  7. Berryman SN, Jennings J, Ragsdale S, Lofton T, Huff DC, Rooker JS (2012) Beers criteria for potentially inappropriate medication use in older adults. Medsurg Nurs 21(3)

  8. Santos AN, Nogueira DR, Gutierrez BA, Chubaci RY, Oliveira CR (2020) Cardiometabolic diseases and active aging - polypharmacy in control. Rev Bras Enferm 73(2):e20180324. https://doi.org/10.1590/0034-7167-2018-0324

  9. Borja-Oliveira CR (2017) Efeitos da carga anticolinérgica cognitiva em idosos – uma revisão integrativa. Estudos Interdisciplinares sobre o Envelhecimento 22(2):57–74. https://doi.org/10.22456/2316-2171.60273

  10. Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev 89(1):73–120. https://doi.org/10.1152/physrev.00015.2008

    Article  CAS  PubMed  Google Scholar 

  11. Ventura ALM, Abreu PA, Freitas RCC, Sathler PC, Loureiro N, Castro HC (2010) Colinergic system: Revisiting receptors, regulation and the relationship with Alzheimer disease, schizophrenia, epilepsy and smoking. Arch Clin Psychiatry 37(2):66–72. https://doi.org/10.1590/S0101-60832010000200007

    Article  Google Scholar 

  12. Caçador C, Teixeira-Lemos E, Oliveira J, Pinheiro J, Teixeira-Lemos L, Ramos F (2022) The Prevalence of Polypharmacy and Potentially Inappropriate Medications and Its Relationship with Cognitive Status in Portuguese Institutionalized Older Adults: A Cross-Sectional Study. Int J Environ Res Public Health 19(5). https://doi.org/10.3390/ijerph19052637

  13. Krüger C (2021) Comparison of FORTA, PRISCUS and EU(7)-PIM lists on identifying potentially inappropriate medication and its impact on cognitive function in multimorbid elderly German people in primary care: A multicentre observational study. BMJ Open 11(9). https://doi.org/10.1136/bmjopen-2021-050344

  14. Aquino EML et al (2012) Brazilian Longitudinal Study of Adult health (ELSA-Brasil): Objectives and design. Am J Epidemiol 175(4):315–324. https://doi.org/10.1093/aje/kwr294

    Article  PubMed  Google Scholar 

  15. Passos VM, Ladeira RM, Souza CC, Santos ID, Barreto SM (2018) First stages chronic kidney disease have mild effects on cognitive performance. Results of a 15,105 brazilian adult baseline cohort. J Bras Nefrol 40(1):18–25. https://doi.org/10.1590/1678-4685-JBN-3889

  16. Chor D et al (2013) Questionario do ELSA-Brasil: desafios na elaboracao de instrumento multidimensional. Rev Saude Publica 47(suppl 2):27–36. https://doi.org/10.1590/s0034-8910.2013047003835

    Article  PubMed  Google Scholar 

  17. Schmidt MI et al (2015) Cohort profile: Longitudinal study of adult health (ELSA-Brasil). Int J Epidemiol 44(1):68–75. https://doi.org/10.1093/ije/dyu027

    Article  PubMed  Google Scholar 

  18. Passos VM, Caramelli P, Benseñor I, Giatti L, Barreto SM (2014) Métodos de investigação da função cognitiva no estudo longitudinal de Saúde do Adulto (ELSA-Brasil). Sao Paulo Med J 132(3):170–177. https://doi.org/10.1590/1516-3180.2014.1323646

  19. Akiyama H (2011) CERAD (The Consortium to Establish a Registry for Alzheimer’s Disease) criteria. Nihon Rinsho 69(Suppl 1, no. Pt 2):264–269

  20. Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo Neto J, Ramos LR (2001) Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 59(3A):532–536. https://doi.org/10.1590/s0004-282x2001000400009

  21. Nunes MA, Alves MD, Chor D, Schmidt MI, Duncan BB (2011) Cross-cultural adaptation of CIS-R (Clinical Interview Schedule-Revised Version) for the portuguese in Longitudinal Study Of Adult Health (ELSA). Hcpa 31(4):487–490. [Online]. Available: http://seer.ufrgs.br/hcpa488

  22. Pitanga FJ, Matos S, Almeida MD, Barreto SM, Aquino EM (2018) Leisure-time physical activity, but not commuting physical activity, is associated with cardiovascular risk among ELSA-Brasil participants. Arq Bras Cardiol 110(1):36–43. https://doi.org/10.5935/abc.20170178

  23. Sönnerstam E, Sjölander M, Gustafsson M (2017) An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list. Eur J Clin Pharmacol 73(6):735–742. https://doi.org/10.1007/s00228-017-2218-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Maclagan LC et al (2017) Frailty and Potentially Inappropriate Medication Use at Nursing Home Transition. J Am Geriatr Soc 65(10):2205–2212. https://doi.org/10.1111/jgs.15016

    Article  PubMed  Google Scholar 

  25. Stuss DT, Levine B (2002) Adult clinical neuropsychology: Lessons from studies of the frontal lobes. Annu Rev Psychol 53(February 2002):401–433. https://doi.org/10.1146/annurev.psych.53.100901.135220

  26. Mattay VS, Goldberg TE, Sambataro F, Weinberger DR (2008) Neurobiology of cognitive aging: Insights from imaging genetics. Biol Psychol 79(1):9–22. https://doi.org/10.1016/j.biopsycho.2008.03.015

    Article  PubMed  PubMed Central  Google Scholar 

  27. Richardson K et al (2018) Anticholinergic drugs and risk of dementia: Case-control study. BMJ 361:1–12. https://doi.org/10.1136/bmj.k1315

    Article  Google Scholar 

  28. Connor MNO, Gallagher P, Mahony DO (2002) Inappropriate prescribing. N Z Med J 115(1146):28. https://doi.org/10.2165/11632610-000000000-00000

  29. Hafdi M, Hoevenaar-Blom MP, Beishuizen CRL, Moll van Charante EP, Richard E, van Gool WA (2020) Association of Benzodiazepine and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults. J Am Med Dir Assoc 21(2):188-193.e3. https://doi.org/10.1016/j.jamda.2019.05.010

    Article  PubMed  Google Scholar 

  30. Chuang YF, Elango P, Gonzalez CE, Thambisetty M (2017) Midlife anticholinergic drug use, risk of Alzheimer’s disease, and brain atrophy in community-dwelling older adults. Alzheimer’s Dement Transl Res Clin Interv 3(3):471–479. https://doi.org/10.1016/j.trci.2017.06.004

    Article  Google Scholar 

  31. Cai X, Campbell N, Khan B, Callahan C, Boustani M (2013) Long-term anticholinergic use and the aging brain. Alzheimer’s Dement 9(4):377–385. https://doi.org/10.1016/j.jalz.2012.02.005

    Article  Google Scholar 

  32. Iyer S et al (2020) Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study. Int Urogynecol J 31(12):2653–2660. https://doi.org/10.1007/s00192-019-04140-3

    Article  PubMed  Google Scholar 

  33. Zelazo PD, Craik FIM, Booth L (2004) Executive function across the life span. Acta Psychol (Amst) 115(2–3):167–183. https://doi.org/10.1016/j.actpsy.2003.12.005

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The ELSA-Brasil study was supported by the Brazilian Ministry of Health and the CNPq (grants 01060010.00RS, 01060212.00BA, 01060300.00ES, 01060278.00MG, 01060115.00SP, 01060071.00RJ). DSF-I received a scholarship from São Paulo Research Foundation (FAPESP) (2017/24066-1).

Author information

Authors and Affiliations

Authors

Contributions

ANMS: design, statistical analysis, and manuscript draft. DSF-I: statistical analysis, critical revision of the manuscript, and approval of the final manuscript version. IMB: funding, critical revision of the manuscript, and approval of the final manuscript version. ACG: critical revision of the manuscript, and approval of the final manuscript version. ARB: critical revision of the manuscript, and approval of the final manuscript version. MCV: funding, critical revision of the manuscript, and approval of the final manuscript version. PAL: funding, critical revision of the manuscript, and approval of the final manuscript version. CKS: design, statistical analysis, supervision, and manuscript draft.

Corresponding author

Correspondence to Adriana Nancy Medeiros dos Santos.

Ethics declarations

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publish

Not applicable.

Competing interests

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The manuscript has not been submitted or published elsewhere.

The original online version of this article was revised: The correct family name of the 2nd Author is Itao not Iao.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 37 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

dos Santos, A.N.M., Farias-Itao, D.S., Benseñor, I.M. et al. Potentially inappropriate medications and cognitive performance: cross-sectional results from the ELSA–Brasil study. Eur J Clin Pharmacol 79, 927–934 (2023). https://doi.org/10.1007/s00228-023-03504-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-023-03504-5

Keywords

Navigation